Dow Up 0.76% Nasdaq Up 0.69%

TrovaGene, Inc. (TROV)

-NasdaqCM
4.37 Down 0.08(1.80%) Oct 24, 3:59PM EDT
Prev Close:4.45
Open:4.45
Bid:4.30 x 1000
Ask:4.37 x 600
1y Target Est:9.00
Beta:0.75
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:4.30 - 4.50
52wk Range:2.97 - 7.24
Volume:50,702
Avg Vol (3m):164,332
Market Cap:82.60M
P/E (ttm):N/A
EPS (ttm):-0.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for TROV

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):326.40
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.74
Quarterly EPS Est (Sep-14) :-0.25
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Trovagene, Inc., a development stage molecular diagnostic company, focuses on the development and commercialization of a proprietary urine-based molecular diagnostic technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback